BioLife Solutions, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$406M
↑+1.6% +$6Mvs FY2024
Total Liabilities
$34M
↓-32.8% -$17Mvs FY2024
Equity
$372M
↑+6.6% +$23Mvs FY2024
Cash
$33M
↓-63.9% -$59Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $406M | $399M |
| Current Assets | $137M | $149M |
| Cash | $33M | $92M |
| ST Investments | $0 | $0 |
| Receivables | $8M | $8M |
| Inventory | $30M | $29M |
| Other Current | $65M | $20M |
| Non-Current Assets | $269M | $251M |
| PPE | $15M | $6M |
| Goodwill | $209M | $209M |
| Intangibles | $4M | $6M |
| Investments | $0 | $0 |
| Other Non-Current | $42M | $31M |
| Total Liab+Eq | $406M | $399M |
| Current Liab. | $23M | $33M |
| Accounts Payable | $1M | $3M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $195K | $103K |
| Other CL | $21M | $29M |
| Non-Current Liab. | $11M | $18M |
| Long-Term Debt | $5M | $16M |
| Other LT Liab. | $6M | $2M |
| Equity | $372M | $349M |
| Retained Earnings | $340M | $335M |
| Other Equity | $32M | $14M |
QuarterCharts · SEC EDGAR data · BLFS · Comparing FY2025 vs FY2024